|
ZNF669 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.26380000026383E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.60950003009242E-09 |
| Normal-vs-Stage2 |
1.83148999999272E-05 |
| Normal-vs-Stage3 |
4.73129999956079E-07 |
| Normal-vs-Stage4 |
5.20980000029425E-07 |
| Stage1-vs-Stage2 |
6.271000E-01 |
| Stage1-vs-Stage3 |
8.291800E-01 |
| Stage1-vs-Stage4 |
3.503600E-01 |
| Stage2-vs-Stage3 |
7.725600E-01 |
| Stage2-vs-Stage4 |
7.264800E-01 |
| Stage3-vs-Stage4 |
4.884400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.31110000212954E-09 |
| Normal-vs-AfricanAmerican |
4.020100E-03 |
| Normal-vs-Asian |
4.034399999997E-05 |
| Caucasian-vs-AfricanAmerican |
3.575600E-01 |
| Caucasian-vs-Asian |
7.536600E-01 |
| AfricanAmerican-vs-Asian |
2.869800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.38449999745427E-08 |
| Normal-vs-Female |
6.70569999972059E-07 |
| Male-vs-Female |
3.864800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.25909999993246E-08 |
| Normal-vs-Age(41-60Yrs) |
1.16280000073132E-08 |
| Normal-vs-Age(61-80Yrs) |
6.97309999964091E-07 |
| Normal-vs-Age(81-100Yrs) |
2.911700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.207800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.990800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.034600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.662800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.943200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.825200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.670600E-01 |
| Classical-VS-Follicular |
3.683900E-03 |
| Classical-VS-Other |
2.256400E-01 |
| Classical-VS-Normal |
2.06239999999136E-05 |
| Tall-VS-Follicular |
4.665000E-01 |
| Tall-VS-Other |
5.190200E-01 |
| Tall-VS-Normal |
1.6672599999934E-05 |
| Follicular-VS-Other |
8.229200E-01 |
| Follicular-VS-Normal |
4.6538000120222E-09 |
| Other-VS-Normal |
9.777900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.11330000166043E-08 |
| Normal-vs-N1 |
9.00069999976161E-07 |
| N0-vs-N1 |
4.265000E-01 |
|
|
